CLINICAL_TRIALS
trial_result
· 2019-10-02
Clinical Trial Update: Secondary Adjuvant Long Term Study With Arimidex [Phase 3]
Summary
Phase 3 long-term secondary adjuvant trial of Arimidex in breast cancer has completed; results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED | Results posted: 2019-10-02